Wellcome Trust award to study link between immune system and brain disorders to investigate whether mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer’s, could be treated by targeting the immune system.
The project, which has received a Strategic Award of £5 million is run by consortium of seven Universities including Cambridge and two companies.
This will be a joint programme of work building on the complementary resources and expertise of all parties. The commercial partners in the project will contribute financial support, drug discovery know-how, preclinical models, imaging expertise, and access to anti-inflammatory drugs. The academic partners will contribute expertise in neuroimaging, clinical phenotyping and trials, animal models, and informatics.